HealthCare Global Enterprises Limited carries a market capitalization of 97.43B, placing it among publicly traded companies globally. Its enterprise value stands at 86.92B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 97.43B |
| Enterprise Value | 86.92B |
HealthCare Global Enterprises Limited currently has 149.30M shares outstanding.
| Shares Outstanding | 149.30M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
HealthCare Global Enterprises Limited trades at a trailing price-to-earnings ratio of 539.99. The price-to-sales ratio is 2.93, and the price-to-book ratio stands at 49.77.
| PE Ratio | 539.99 |
| PS Ratio | 2.93 |
| PB Ratio | 49.77 |
| P/TBV Ratio | 7.51 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, HealthCare Global Enterprises Limited trades at an EV/EBITDA multiple of 39.22 and an EV/FCF ratio of 58.17. The EV/Sales ratio of 3.42 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 39.22 provides insight into valuation relative to core operating earnings.
| EV / Sales | 3.42 |
| EV / EBITDA | 39.22 |
| EV / EBIT | 39.22 |
| EV / FCF | 58.17 |
HealthCare Global Enterprises Limited maintains a current ratio of 1.12, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 123.06, indicating elevated leverage, while an interest coverage ratio of 1.26 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.12 |
| Quick Ratio | 0.54 |
| Debt / Equity | 123.06 |
| Debt / EBITDA | 7.83 |
| Interest Coverage | 1.26 |
HealthCare Global Enterprises Limited posts a return on equity of 25.22 and a return on invested capital of 6.36.
| Return on Equity (ROE) | 25.22 |
| Return on Assets (ROA) | 0.37 |
| Return on Invested Capital (ROIC) | 6.36 |
| Return on Capital Employed (ROCE) | 8.57 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 22.00 |
Over the trailing twelve months, HealthCare Global Enterprises Limited has paid 41.40M in income taxes, reflecting an effective tax rate of 15.38.
| Income Tax | 41.40M |
| Effective Tax Rate | 15.38 |
HealthCare Global Enterprises Limited's stock has gained approximately 16.47332% over the past 52 weeks. The 50-day moving average sits at 623.04, while the 200-day moving average is 637.36.
| Beta (5Y) | N/A |
| 52-Week Price Change | 16.47332% |
| 50-Day Moving Average | 623.04 |
| 200-Day Moving Average | 637.36 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, HealthCare Global Enterprises Limited generated 25.38B in revenue and converted that into 137.60M in net income, yielding earnings per share of 1.61. EBITDA reached 2.22B, while operating income came in at 2.22B.
| Revenue | 25.38B |
| Gross Profit | 12.97B |
| Operating Income | 2.22B |
| Pretax Income | 269.20M |
| Net Income | 137.60M |
| EBITDA | 2.22B |
| EBIT | 2.22B |
| Earnings Per Share (EPS) | 1.61 |
HealthCare Global Enterprises Limited holds 5.52B in cash and equivalents against 17.35B in total debt, resulting in a net debt position of 3.74B. Total book value stands at 1.49B, with working capital of 1.18B providing operational flexibility.
| Cash & Cash Equivalents | 5.52B |
| Total Debt | 17.35B |
| Net Debt | 3.74B |
| Equity (Book Value) | 1.49B |
| Book Value Per Share | 10.55 |
| Working Capital | 1.18B |
HealthCare Global Enterprises Limited operates with a gross margin of 51.10, reflecting its pricing power and cost economics. The operating margin of 8.73 and net profit margin of 0.54 provide insight into operational efficiency.
| Gross Margin | 51.10 |
| Operating Margin | 8.73 |
| Pretax Margin | 1.06 |
| Profit Margin | 0.54 |
| EBITDA Margin | 8.73 |
HealthCare Global Enterprises Limited posts an Altman Z-Score of 2.75, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 2.75 |